Relationship between autoantibodies to erythropoietin receptor and renal outcome in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

References

• Bhamra, K. and Luqmani, R., 2012. Damage assessment in ANCA-associated vasculitis. Current rheumatology reports, 14 (6), 494–500.
   PubMed Web of Science ®Google Scholar
• De Beuf, A., et al., 2010. Epoetin delta reduces oxidative stress in primary human renal tubular cells. Journal of biomedicine and biotechnology, 2010, 1–9.
   Google Scholar
• Furuta, S. and Jayne, D.R., 2013. Antineutrophil cytoplasm antibody-associated vasculitis: recent developments. Kidney international, 84 (2), 244–249.
   PubMed Web of Science ®Google Scholar
• Group, J.J.W., 2011. Guideline for management of vasculitis syndrome (JCS 2008). Circulation journal, 75 (2), 474–503.
   PubMed Web of Science ®Google Scholar
• Guillevin, L. and Terrier, B., 2014. Microscopic polyangiitis. In: G.V. Ball, B.J. Fessler & J. S. Louis Bridges, eds. Oxford textbook of vasculitis. 3rd ed. Oxford: Oxford University Press, 351–361.
   Google Scholar
• Hao, J., et al., 2014. The association between anti-plasminogen antibodies and disease activity in ANCA-associated vasculitis. Rheumatology (Oxford), 53 (2), 300–306.
   PubMed Web of Science ®Google Scholar
• Hara, A., et al., 2008. Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies. American journal of hematology, 83 (9), 750–752.
   PubMed Web of Science ®Google Scholar
• Hara, A., et al., 2013. Autoantibodies to erythropoietin receptor in patients with immune-mediated diseases: relationship to anaemia with erythroid hypoplasia. British journal of haematology, 160 (2), 244–250.
   PubMed Web of Science ®Google Scholar
• Hara, A., et al., 2016. Effect of autoantibodies to erythropoietin receptor in systemic lupus erythematosus with biopsy-proven lupus nephritis. The journal of rheumatology, 43 (7), 1328–1334.
   PubMed Web of Science ®Google Scholar
• Hara, A., et al., 2018. Clinical and pathological significance of autoantibodies to erythropoietin receptor in type 2 diabetic patients with CKD. Kidney international reports, 3 (1), 133–141.
   PubMed Web of Science ®Google Scholar
• Haroon, Z.A., et al., 2003. A novel role for erythropoietin during fibrin-induced wound-healing response. American journal of pathology, 163 (3), 993–1000.
   PubMed Web of Science ®Google Scholar
• Hellmich, B., et al.; on behalf of the European Vasculitis Study Group, 2007. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Annals of the rheumatic diseases, 66 (5), 605–617.
   PubMed Web of Science ®Google Scholar
• Leone, A.M., et al., 2009. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. European heart journal, 30 (8), 890–899.
   PubMed Web of Science ®Google Scholar
• Marzano, A.V., et al., 2017. Cutaneous manifestations of ANCA-associated small vessels vasculitis. Clinical reviews in allergy & immunology, 53 (3), 428–438.
   PubMed Web of Science ®Google Scholar
• Matsuo, S., et al., 2009. Revised equations for estimated GFR from serum creatinine in Japan. American journal of kidney diseases, 53 (6), 982–992.
   PubMed Web of Science ®Google Scholar
• Mukhtyar, C., et al., 2009. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Annals of the rheumatic diseases, 68 (12), 1827–1832.
   PubMed Web of Science ®Google Scholar
• Neumann, I., et al., 2005. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrology dialysis transplantation, 20 (1), 96–104.
   PubMed Web of Science ®Google Scholar
• Ntatsaki, E., et al.; Bsr, Bhpr Standards, G. & Audit Working, G., 2014. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology, 53 (12), 2306–2309.
   PubMed Web of Science ®Google Scholar
• Pearl, R.G., 2014. Erythropoietin and organ protection: lessons from negative clinical trials. Critical care, 18 (5), 526.
   PubMed Web of Science ®Google Scholar
• Rhee, R.L., et al., 2016. Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease. Arthritis and rheumatology, 68 (7), 1711–1720.
   PubMed Web of Science ®Google Scholar
• Slot, M.C., et al., 2003. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney international, 63 (2), 670–677.
   PubMed Web of Science ®Google Scholar
• Sorg, H., et al., 2013. The nonhematopoietic effects of erythropoietin in skin regeneration and repair: from basic research to clinical use. Medicinal research reviews, 33 (3), 637–664.
   PubMed Web of Science ®Google Scholar
• Stone, J.H., et al., 2001. A disease‐specific activity index for Wegener’s granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis and rheumatism, 44 (4), 912–920.
   PubMed Web of Science ®Google Scholar
• Suzuki, K., et al., 2014. A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis. Nephrology dialysis transplantation, 29 (6), 1168–1177.
   PubMed Web of Science ®Google Scholar
• Watts, R., et al., 2007. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Annals of the rheumatic diseases, 66 (2), 222–227.
   PubMed Web of Science ®Google Scholar
• Weiner, M., et al., 2015. Outcome and treatment of elderly patients with ANCA-associated vasculitis. Clinical journal of the American society of nephrology, 10 (7), 1128–1135.
   PubMed Web of Science ®Google Scholar
• Wilde, B., et al., 2011. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney international, 79 (6), 599–612.
   PubMed Web of Science ®Google Scholar
• Woodward, M., 2013. Epidemiology: study design and data analysis, 3rd ed. Boca Raton, FL: CRC Press.
   Google Scholar
• Zavada, J., et al., 2009. Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford), 48 (10), 1197–1201.
   PubMed Web of Science ®Google Scholar